These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10525511)

  • 21. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ; Lim JK
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.
    Devereaux PJ; Anderson DR; Gardner MJ; Putnam W; Flowerdew GJ; Brownell BF; Nagpal S; Cox JL
    BMJ; 2001 Nov; 323(7323):1218-22. PubMed ID: 11719412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
    Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now.
    Bajorek BV; Ren S
    Int J Clin Pharm; 2012 Feb; 34(1):88-97. PubMed ID: 22179941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.
    Steinberg BA; Greiner MA; Hammill BG; Curtis LH; Benjamin EJ; Heckbert SR; Piccini JP
    Cardiovasc Ther; 2015 Aug; 33(4):177-83. PubMed ID: 25930214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic treatment of atrial fibrillation in a regional hospital in Hong Kong.
    Leung CS; Tam KM
    Hong Kong Med J; 2003 Jun; 9(3):179-85. PubMed ID: 12777653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
    Go AS; Hylek EM; Phillips KA; Borowsky LH; Henault LE; Chang Y; Selby JV; Singer DE
    Circulation; 2000 Jul; 102(1):11-3. PubMed ID: 10880408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
    Lip GY
    J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC; Albers GW
    Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention.
    Bajorek BV; Krass I; Ogle SJ; Duguid MJ; Shenfield GM
    J Am Geriatr Soc; 2005 Nov; 53(11):1912-20. PubMed ID: 16274372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database.
    Rietbrock S; Plumb JM; Gallagher AM; van Staa TP
    Thromb Haemost; 2009 Mar; 101(3):527-34. PubMed ID: 19277415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of antithrombotic drug usage in atrial fibrillation.
    Ang SY; Peterson GM; Friesen WT; Vial JH
    J Clin Pharm Ther; 1998 Apr; 23(2):97-106. PubMed ID: 9786095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation.
    Lau E; Bungard TJ; Tsuyuki RT
    J Am Geriatr Soc; 2004 Mar; 52(3):428-33. PubMed ID: 14962160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation.
    Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term antithrombotic treatment for atrial fibrillation.
    Nademanee K; Kosar EM
    Am J Cardiol; 1998 Oct; 82(8A):37N-42N. PubMed ID: 9809899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utilization of antithrombotic prophylaxis for atrial fibrillation in a geriatric rehabilitation hospital.
    Lawson F; McAlister F; Ackman M; Ikuta R; Montague T
    J Am Geriatr Soc; 1996 Jun; 44(6):708-11. PubMed ID: 8642165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.